Intravenous methylprednisolone pulse therapy in essential mixed cryoglobulinemia nephropathy.
In 15 patients with essential mixed cryoglobulinemia, 24 exacerbations of renal disease, characterized by an increase in plasma creatinine (13 episodes) and/or proteinuria (18 episodes), were treated by 3 intravenous pulses of methylprednisolone (1 g each), followed by oral prednisone (0.5 mg/kg/day). Plasma creatinine levels fell within a week (P less than 0.025), while a significant decrease in urinary protein excretion was observed only after one month (P less than 0.05). After therapy, plasma creatinine levels remained stable in 8/10 patients for 3 to 60 months. These beneficial results suggest that MP pulses may be useful in the treatment of cryoglobulinemic nephropathy.
D000328:Adult; D000368:Aged; D003449:Cryoglobulinemia / Q000150:complications / Q000188:drug therapy*; D005260:Female; D005921:Glomerulonephritis / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage*; D008875:Middle Aged; D010265:Paraproteinemias / Q000188:drug therapy*; D011241:Prednisone / Q000008:administration & dosage; D011674:Pulse
D011241:Prednisone; D008775:Methylprednisolone